Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease (Q37588723)

21 August 2017

1 reference

title

Emerging oligonucleotide therapies for asthma and chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

21 August 2017

0 references

0 references

author name string

Rosanne M Séguin

series ordinal

1 reference

21 August 2017

Nicolay Ferrari

series ordinal

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Expert Opinion on Investigational Drugs

21 August 2017

published in

1 reference

21 August 2017

1 reference

21 August 2017

1 reference

21 August 2017

page(s)

1505-1517

1 reference

Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Highly efficient endonucleolytic cleavage of RNA by a Cys(2)His(2) zinc-finger peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

MicroRNA targeting specificity in mammals: determinants beyond seed pairing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Therapeutic applications of transcription factor decoy oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

The correlation between asthma control and health status: the GOAL study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Inhaled and systemic corticosteroids in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Targeting the lung using siRNA and antisense based oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Toxicology of antisense therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Antisense technologies. Improvement through novel chemical modifications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Design of phosphorodiamidate morpholino oligomers (PMOs) for the induction of exon skipping of the human DMD gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Antisense-mediated exon skipping: a versatile tool with therapeutic and research applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Adenosine receptors as promising therapeutic targets for drug development in chronic airway inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Sense and antisense: therapeutic potential of oligonucleotides and interference RNA in asthma and allergic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Adenosine receptors and asthma in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Mepolizumab for prednisone-dependent asthma with sputum eosinophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Mepolizumab and exacerbations of refractory eosinophilic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Targeting airway inflammation in asthma: current and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Effects of antisense oligodeoxynucleotides targeting CCR3 on the airway response to antigen in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Adenosine in the airways: implications and applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

The IL-4 receptor: signaling mechanisms and biologic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Leukocyte navigation mechanisms as targets in airway diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Roflumilast fully prevents emphysema in mice chronically exposed to cigarette smoke

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Eat dirt: CpG DNA and immunomodulation of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Use of CpG oligonucleotides in treatment of asthma and allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

CpG motifs in bacterial DNA and their immune effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Immunostimulatory sequences regulate interferon-inducible genes but not allergic airway responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

'Immunomers'--novel 3'-3'-linked CpG oligodeoxyribonucleotides as potent immunomodulatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Novel immunomodulatory oligonucleotides prevent development of allergic airway inflammation and airway hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Modulation of ovalbumin-induced Th2 responses by second-generation immunomodulatory oligonucleotides in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Interfering with disease: a progress report on siRNA-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Syk tyrosine kinase participates in beta1-integrin signaling and inflammatory responses in airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Involvement of Syk protein tyrosine kinase in LPS-induced responses in macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Inhibition of signal transducer and activator of transcription 1 attenuates allergen-induced airway inflammation and hyperreactivity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-alpha expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Potent and nontoxic antisense oligonucleotides containing locked nucleic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Chemical modification of siRNAs for in vivo use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Inefficient cationic lipid-mediated siRNA and antisense oligonucleotide transfer to airway epithelial cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Small interfering RNA targeting heme oxygenase-1 enhances ischemia-reperfusion-induced lung apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Antisense- and RNA interference-based therapeutic strategies in allergy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

DNA antisense therapy for asthma in an animal model

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543780903179294

10.1517/13543780903179294

21 January 2018

Identifiers

DOI

1 reference

21 August 2017

1 reference